A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation

References

• De Conno F, Caraceni A, Zecca E, et al. (1991). Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484–6
   PubMed Web of Science ®Google Scholar
• Fisher DM, Kellett N, Lenhardt R. (2003). Pharmacokinetics of an implanted osmotic pump delivering sufentanil for the treatment of chronic pain. Anesthesiology 99:929–37
   PubMed Web of Science ®Google Scholar
• Fujikawa T, Imbe H, Date M, et al. (2012). Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 97:e31–3
   PubMed Web of Science ®Google Scholar
• González-Michaca L, Ahumada M, Ponce-de-León S. (2002). Insulin subcutaneous application vs. continuous infusion for postoperative blood glucose control in patients with non-insulin-dependent diabetes mellitus. Arch Med Res 33:48–52
   PubMed Web of Science ®Google Scholar
• Grattoni A, Merlo M, Ferrari M. (2007). Osmotic pressure beyond concentration restrictions. J Phys Chem B 111:11770–5
   PubMed Web of Science ®Google Scholar
• Guo JH. (1993). Effects of plasticizers on water permeation and mechanical properties of cellulose-acetate-antiplasticization in slightly plasticized polymer film. Dr Dev Ind Pharm 19:1541–55
   Web of Science ®Google Scholar
• Hansen S, Gustafson R, Smith CIE, et al. (2002). Express subcutaneous IgG infusions: decreased time of delivery with maintained safety. Clin Immunol 104:237–41
   PubMed Web of Science ®Google Scholar
• Hernandez G, Haines E, Shizgal P. (2008). Potentiation of intracranial self-stimulation during prolonged subcutaneous infusion of cocaine. J Neurosci Methods 175:79–87
   PubMed Web of Science ®Google Scholar
• Herrlich S, Spieth S, Messner S, et al. (2012). Osmotic micropumps for drug delivery. Adv Drug Deliv Rev 64:1617–27
   PubMed Web of Science ®Google Scholar
• Herrmanna M, Henneicke H, Street J, et al. (2009). The challenge of continuous exogenous glucocorticoid administration in mice. Steroids 74:245–9
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang HM, Frank MM. (2010). Subcutaneous infusion of human C1 inhibitor in swine. Clin Immunol 136:323–8
   PubMed Web of Science ®Google Scholar
• Kumaravelrajan R, Narayanan N, Suba V, et al. (2010). Simultaneous delivery of nifedipine and metoprolol tartarate using sandwiched osmotic pump tablet system. Int J Pharm 399:60–70
   PubMed Web of Science ®Google Scholar
• Leahy MG, Pitfield D, Popert S, et al. (1992). Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administration. Eur J Cancer 28:1049–51
   Web of Science ®Google Scholar
• Lee H, Cima MJ. (2011). An intravesical device for the sustained delivery of lidocaine to the bladder. J Control Release 149:133–9
   PubMed Web of Science ®Google Scholar
• Liu L, Ku J, Khang G, et al. (2000). Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release 68:145–56
   PubMed Web of Science ®Google Scholar
• Makhija SN, Vavia PR. (2003). Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as a semipermeable membrane. J Control Release 89:5–18
   PubMed Web of Science ®Google Scholar
• Malaterre V, Metz H, Ogorka J, et al. (2009a). Benchtop-magnetic resonance imaging (BT-MRI) characterization on the water-insoluble drug release from push-pull osmotic systems. J Control Release 133:31–6
   PubMed Web of Science ®Google Scholar
• Malaterre V, Ogorka J, Loggia N, et al. (2009b). Approach to design push-pull osmotic pumps. Int J Pharm 376:56–62
   PubMed Web of Science ®Google Scholar
• Marchese G, Pittau B, Casu G, et al. (2010). A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats. Eur Psychiatry 25:92–100
   PubMed Web of Science ®Google Scholar
• Mikkelsen Lynch P, Butler J, Huerta D, et al. (2000). A pharmacokinetic and tolerability evaluation of two continuous subcutaneous infusion systems compared to an oral controlled-release morphine. J Pain Symptom Manage 19:348–56
   PubMed Web of Science ®Google Scholar
• Moulin DE, Kreeft JH, Murray-Parsons N, et al. (1991). Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 337:465–8
   PubMed Web of Science ®Google Scholar
• Ofori-Kwakye K, Fell JT. (2003). Biphasic drug release from film-coated tablets. Int J Pharm 250:431–40
   PubMed Web of Science ®Google Scholar
• Pasero C. (2002). Subcutaneous opioid infusion. Am J Nurs 102:61–2
   Web of Science ®Google Scholar
• Rani M, Mishra B. (2004). Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. AAPS PharmSciTech 5:153--9
   Web of Science ®Google Scholar
• Rose S, Nelson JF. (1955). A continuous long-term injector. Aust J Exp Biol Med Sci 33:415–9
   PubMedGoogle Scholar
• Scholz OA, Wolff A, Schumacher A, et al. (2008). Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Discov Today 13:247–53
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, et al. (2008). Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm 68:289–97
   PubMed Web of Science ®Google Scholar
• Storey P, Hill HH Jr, St Louis RH, et al. (1990). Subcutaneous infusions for control of cancer symptoms. J Pain Symptom Manage 5:33–41
   PubMedGoogle Scholar
• Theeuwes F, Yum SI. (1976). Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 4:343–53
   PubMed Web of Science ®Google Scholar
• Wasserman RL, Melamed I, Stein MR, et al. (2012). Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. J Allergy Clin Immunol 130:951–7
   PubMed Web of Science ®Google Scholar
• Wright JC, Leonard ST, Stevenson, CL, et al. (2001). An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer. J Control Release 75:1–10
   PubMed Web of Science ®Google Scholar
• Özdemir N, Sahin J. (1997). Design of a controlled release osmotic pump system of ibuprofen. Int J Pharm 158:91–7
   Web of Science ®Google Scholar